Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection
Open Access
- 1 March 2001
- journal article
- review article
- Published by Elsevier in Gastroenterology
- Vol. 120 (4), 1000-1008
- https://doi.org/10.1053/gast.2001.22454
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Hepatitis B Virus BiologyMicrobiology and Molecular Biology Reviews, 2000
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapyHepatology, 1999
- Mutations in the hepatitis B virus polymerase gene associated with antiviral treatment for hepatitis BJournal of Viral Hepatitis, 1999
- A One-Year Trial of Lamivudine for Chronic Hepatitis BNew England Journal of Medicine, 1998
- Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsidsThe EMBO Journal, 1997
- Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase.Proceedings of the National Academy of Sciences, 1996
- Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopyCell, 1994
- Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BAnnals of Internal Medicine, 1993
- VIRUS-LIKE PARTICLES IN SERUM OF PATIENTS WITH AUSTRALIA-ANTIGEN-ASSOCIATED HEPATITISThe Lancet, 1970